Empirical Evaluation of the Possible Contribution of Group Practice of the Transcendental Meditation and TM-Sidhi Program to Reduction in Drug-Related Mortality

Author:

Dillbeck Michael C.1,Cavanaugh Kenneth L.1

Affiliation:

1. Dr. Tony Nader Institute for Research on Consciousness and Its Applied Technologies, Maharishi International University, Fairfield, IA 52557, USA

Abstract

Background and Objectives: CDC data indicate that the U.S. is experiencing a sustained epidemic of drug-related mortality, with such deaths exceeding a record 100,000 in 2021, up 47% from 2019. Opioids, especially the synthetic opioid fentanyl, account for approximately 75% of this mortality. This study evaluates a proposed Consciousness-Based® approach that may possibly help reduce trends in drug-related fatalities by mitigating what WHO refers to as an “epidemic of stress” in society that helps fuel drug misuse and other negative public health trends. This approach involves providing support in public and private sector public health initiatives for individual and group practice of a subjective, evidence-based meditation procedure suitable for those of all educational, cultural, and religious backgrounds: the Transcendental Meditation® (TM®) technique and its advanced aspect, the TM-Sidhi® program. Materials and Methods: Segmented-trend regression analysis of monthly CDC data on U.S. drug-related fatality rates (dfr) from a prospective social experiment (2002–2016) was used to replicate and extend prior peer-reviewed research. Results: As hypothesized, (1) practice of the TM and TM-Sidhi program by a group of theoretically predicted size (√1% of the U.S. population) was associated with a statistically and practically significant reduction in dfr trend during the five-year “demonstration period” of the quasi-experiment; and (2) monthly dfr trend subsequently increased during the five-year follow-up period when the group fell below the required size (both p’s < 0.0001). The estimated total percent decrease in dfr during the demonstration period was 35.5%, calculated relative to the baseline mean. This decline was followed by total dfr increases of 11.8% and 47.4% relative to the demonstration-period mean during the two phases of the follow-up period. Conclusion: Existing evidence warrants implementation and further evaluation of this approach in U.S. public health initiatives.

Funder

MIU’s College of Business Administration

Tony Nader Institute for Research on Consciousness at MIU

Publisher

MDPI AG

Subject

General Medicine

Reference118 articles.

1. Commission on Combating Synthetic Opioid Trafficking (2023, January 15). Commission on Combating Synthetic Opioid Trafficking: Final Report. Santa Monica, CA: The RAND Corporation. Available online: https://www.rand.org/pubs/external_publications/EP68838.html.

2. Lopez, G., and A Rising Death Toll (2023, January 15). The New York Times: The Morning. Available online: https://www.nytimes.com/2022/02/13/briefing/opioids-drug-overdose-death-toll.html.

3. Centers for Disease Control and Prevention, and National Center for Health Statistics (2023, January 15). Drug Overdose Deaths in the U.S. Top 100,000 Annually (Press Release), Available online: https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2021/20211117.htm.

4. American Medical Association (2023, January 15). 2021 Overdose Epidemic Report. AMA: Chicago, IL, USA. Available online: https://end-overdose-epidemic.org/wp-content/uploads/2021/09/AMA-2021-Overdose-Epidemic-Report_92021.pdf.

5. Centers for Disease Control and Prevention (2023, January 15). Drug Overdose Deaths Remain High, Available online: https://www.cdc.gov/drugoverdose/deaths/index.html.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3